Characterization and temporal development of cores in a mouse model of malignant hyperthermia
- PMID: 19966218
- PMCID: PMC2799858
- DOI: 10.1073/pnas.0911496106
Characterization and temporal development of cores in a mouse model of malignant hyperthermia
Abstract
Malignant hyperthermia (MH) and central core disease are related skeletal muscle diseases often linked to mutations in the type 1 ryanodine receptor (RYR1) gene, encoding for the Ca(2+) release channel of the sarcoplasmic reticulum (SR). In humans, the Y522S RYR1 mutation is associated with malignant hyperthermia susceptibility (MHS) and the presence in skeletal muscle fibers of core regions that lack mitochondria. In heterozygous Y522S knock-in mice (RYR1(Y522S/WT)), the mutation causes SR Ca(2+) leak and MHS. Here, we identified mitochondrial-deficient core regions in skeletal muscle fibers from RYR1(Y522S/WT) knock-in mice and characterized the structural and temporal aspects involved in their formation. Mitochondrial swelling/disruption, the initial detectable structural change observed in young-adult RYR1(Y522S/WT) mice (2 months), does not occur randomly but rather is confined to discrete areas termed presumptive cores. This localized mitochondrial damage is followed by local disruption/loss of nearby SR and transverse tubules, resulting in early cores (2-4 months) and small contracture cores characterized by extreme sarcomere shortening and lack of mitochondria. At later stages (1 year), contracture cores are extended, frequent, and accompanied by areas in which contractile elements are also severely compromised (unstructured cores). Based on these observations, we propose a possible series of events leading to core formation in skeletal muscle fibers of RYR1(Y522S/WT) mice: Initial mitochondrial/SR disruption in confined areas causes significant loss of local Ca(2+) sequestration that eventually results in the formation of contractures and progressive degradation of the contractile elements.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Galli L, et al. Mutations in the RYR1 gene in Italian patients at risk for malignant hyperthermia: Evidence for a cluster of novel mutations in the C-terminal region. Cell Calcium. 2002;32:143–151. - PubMed
-
- Monnier N, et al. Presence of two different genetic traits in malignant hyperthermia families: Implication for genetic analysis, diagnosis, and incidence of malignant hyperthermia susceptibility. Anesthesiology. 2002;97:1067–1074. - PubMed
-
- MacLennan DH, Phillips MS. Malignant hyperthermia. Science. 1992;256:789–794. - PubMed
-
- Magee KR, Shy GM. A new congenital non-progressive myopathy. Brain. 1956;79:610–621. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials
Miscellaneous
